Intellectual Property Appellate Board
- All
- News
- Videos
-
Facebook Posts Not Determinative Of A Person's Location: Delhi Court
- Wednesday December 14, 2022
- India News | Press Trust of India
A court cannot treat Facebook posts as determinative of the location of a person at a particular point of time, the Delhi High Court has said, while allowing the plea of a lawyer against an order of the Intellectual Property Appellate Board (IPAB).
-
www.ndtv.com
-
Supreme Court backs generics in Novartis drug patent ruling
- Monday April 1, 2013
- India News | Agence France-Presse
India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect access to cheap generic drugs and save lives in developing nations.
-
www.ndtv.com
-
Patent board rules against Bayer in cancer drug case
- Tuesday March 5, 2013
- India News | Reuters
A patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.
-
www.ndtv.com
-
Facebook Posts Not Determinative Of A Person's Location: Delhi Court
- Wednesday December 14, 2022
- India News | Press Trust of India
A court cannot treat Facebook posts as determinative of the location of a person at a particular point of time, the Delhi High Court has said, while allowing the plea of a lawyer against an order of the Intellectual Property Appellate Board (IPAB).
-
www.ndtv.com
-
Supreme Court backs generics in Novartis drug patent ruling
- Monday April 1, 2013
- India News | Agence France-Presse
India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect access to cheap generic drugs and save lives in developing nations.
-
www.ndtv.com
-
Patent board rules against Bayer in cancer drug case
- Tuesday March 5, 2013
- India News | Reuters
A patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.
-
www.ndtv.com